Niagen IV.
Niagen IV is a pharmaceutical-grade intravenous therapy that delivers nicotinamide riboside (NR), a well-known NAD+ precursor, directly into the bloodstream. By bypassing the digestive system, Niagen IV aims to rapidly elevate cellular NAD+ levels—supporting energy production, DNA repair, and healthier aging.
Niagen IV BENEFITS
As we age, NAD levels naturally decline, which can contribute to metabolic dysfunction, fatigue, and cellular aging. Fortunately, nicotinamide riboside (NR), a direct precursor to NAD, offers a solution. Available in supplement and intravenous (IV) form, Niagen is a well-tolerated product that boosts NAD levels efficiently, providing numerous health benefits.
The Role of NAD in Sirtuin Metabolism and Mitochondrial Health
NAD plays a critical role in activating sirtuins, a family of proteins responsible for regulating cellular health. Sirtuins are key players in mitochondrial function, stress resistance, and inflammation modulation.
NAD and Chronic Fatigue Syndrome
For individuals with chronic fatigue syndrome (CFS), NAD can be a game-changer. CFS is characterized by persistent exhaustion and mitochondrial dysfunction.
NAD for Mild – to – Moderate COVID Recovery
COVID, a condition marked by symptoms such as fatigue, brain fog, and muscle weakness, has been linked to mitochondrial dysfunction and inflammation. NAD’s ability to enhance mitochondrial efficiency and reduce oxidative stress makes it a promising therapy accelerated recovery for those with COVID
Why Choose Niagen?
Niagen, a clinically studied form of NR, offers a reliable way to boost NAD levels. Administered orally or through IV therapy, Niagen is well-tolerated and rapidly absorbed, making it an effective tool for enhancing longevity and addressing specific health challenges.
Important Considerations
The direct contraindications for NAD therapy include an active cancer diagnosis, pregnancy, and lactation. For individuals with chronic kidney disease, treatment is subject to provider discretion
IV Administration Protocol
The IV administration of NAD is typically done in a loading dose fashion, involving 3-5 consecutive days of IV therapy, followed by maintenance doses every 2-4 weeks. Between IV sessions, patients are given oral nicotinamide riboside to sustain NAD levels and prevent declines.